Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 43, 4530-4536, October 1, 1983]
© 1983 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oláh, E.
Right arrow Articles by Somfai-Relle, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oláh, E.
Right arrow Articles by Somfai-Relle, S.

Effects of Some Sugar Alcohol Derivatives on Mutation and Induction of Sister Chromatid Exchanges

Edith Oláh1, Károly Tóth, János Sugár, Lajos Hegedüs and Susan Somfai-Relle

National Oncological Institute, Research Institute of Oncopathology, H-1122 Budapest [E. O., K. T., J. S., S. S.-R.], and Chinoin Chemical and Pharmaceutical Works, Budapest [L. H.], Hungary

The mutagenicity of various alkylating sugar alcohol derivatives in the Salmonella-microsome assay was studied, and the effects of these compounds on the colony-forming ability and the frequency of sister chromatid exchange (SCE) in Chinese hamster cells were determined.

Cytostatic drugs under clinical trial [Elobromol (DBD), Myelobromol (DBM), Lycurim (LY), Zitostop (ZI)], others in preclinical analysis [dianhydrogalactitol (DAG), 3,4-diacetyldianhydrogalactitol (DiacDAG), 3,4-disuccinyldianhydrogalactitol (DisuDAG)], and compounds without any known antitumor effect in trans-plantable tumors [1-bromo-3,6-anhydrodulcitol (BAD), 1,2-epoxi-3,6-anhydrodulcitol (EAD)] were examined.

All the tested compounds except DisuDAG were directly mutagenic in Salmonella strains TA 1535 and TA 100. The mutagenic effect of the chemicals was not influenced by S9 mix from rat liver, with the exception of ZI and DiacDAG.

DisuDAG appeared nonmutagenic in strains TA 1535 and TA 100 exposed to microsomal enzymes from rat liver, lung, and kidney and mouse and hamster liver, nor was DisuDAG mutagenic in strains TA 1537, TA 1538, and TA 98 in either the presence or the absence of rat liver S9 mix. Mouse urine, after a single administration of DisuDAG to the animal, proved to be mutagenic in strain TA 1535. This effect can be attributed to the presence of DAG and EAD which could be identified by thinlayer chromatography of urine, thus establishing the premutagenic character of DisuDAG.

All sugar alcohol derivatives increased the frequency of SCE. Doses required to double the control SCE frequency were in the sublethal range of the survival curve for DBD, DBM, LY, DAG, and DiacDAG. Doses higher than the sublethal ones were required of ZI, DisuDAG, BAD, and EAD to achieve a 2-fold increase in SCE frequency. On the basis of these doses, the relative potencies for SCE induction of the compounds were as follows: EAD < BAD < DisuDAG < ZI < DiacDAG < DAG < DBD < DBM < LY. Within this range, there was a 2 million-fold difference in the SCE production of these chemically related compounds.

1 To whom requests for reprints should be addressed.

Received 1/28/83. Accepted 6/22/83.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1983 by the American Association for Cancer Research.